Skip to main content
Journal cover image

Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.

Publication ,  Journal Article
Akbar, M; Abel, R; Seyler, TM; Bedke, J; Haferkamp, A; Gerner, HJ; Möhring, K
Published in: BJU Int
September 2007

OBJECTIVES: To examine the effects of repeated detrusor injections of botulinum-A toxin (BTX) for possible changes in bladder function, muscular structure of the detrusor, increase in BTX tolerance (tachyphylaxis) and side-effects, as BTX is a new treatment alternative for patients with a neurogenic bladder condition that is difficult to treat and refractory to anticholinergic medication. PATIENTS AND METHODS: Between 2000 and 2005, 19 patients with myelodysplasia (MDP) and 25 spinal cord-injured (SCI) patients were treated with repeated suburothelial BTX injections (Dysport, Ipsen-Pharma, Ettlingen, Germany) or injections into the intramural detrusor. The follow-up was > or = 3 years (range 3-5, median 4.5). RESULTS: Detrusor compliance, bladder capacity, and detrusor pressure at maximum filling improved significantly (P < 0.001) compared to baseline after each BTX injection. There was prolonged efficacy of each BTX administration and all repeated injections in the paediatric and adult patients with neurogenic bladder dysfunction over a median follow-up of 4.5 years. There was no evidence for drug tolerance or changes in the morphological appearance of the bladder. Safety was good: no complications were associated with the injection procedure itself. Early in the treatment programme, three patients who received a dose of 1000 units Dysport showed systemic side-effects and generalized muscle weakness. These resolved without intervention and did not recur after reducing the adult dose to 750 units (paediatric dose 20 units/kg, not >400 units), which seems to be the optimum for good efficacy with an adequate safety margin. CONCLUSION: BTX injection is a safe and effective treatment for neurogenic detrusor hyperreflexia. Repeat treatments are as effective as the first: there was no indication of a lack of efficacy due to tachyphylaxis, antibody formation, or fibrosis of the detrusor muscle in this sample.

Duke Scholars

Published In

BJU Int

DOI

ISSN

1464-4096

Publication Date

September 2007

Volume

100

Issue

3

Start / End Page

639 / 645

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Urodynamics
  • Urinary Bladder, Neurogenic
  • Treatment Outcome
  • Spinal Cord Injuries
  • Retrospective Studies
  • Neuromuscular Agents
  • Neural Tube Defects
  • Male
  • Injections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Akbar, M., Abel, R., Seyler, T. M., Bedke, J., Haferkamp, A., Gerner, H. J., & Möhring, K. (2007). Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int, 100(3), 639–645. https://doi.org/10.1111/j.1464-410X.2007.06977.x
Akbar, Michael, Rainer Abel, Thorsten M. Seyler, Jens Bedke, Axel Haferkamp, Hans J. Gerner, and Klaus Möhring. “Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.BJU Int 100, no. 3 (September 2007): 639–45. https://doi.org/10.1111/j.1464-410X.2007.06977.x.
Akbar, Michael, et al. “Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.BJU Int, vol. 100, no. 3, Sept. 2007, pp. 639–45. Pubmed, doi:10.1111/j.1464-410X.2007.06977.x.
Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int. 2007 Sep;100(3):639–645.
Journal cover image

Published In

BJU Int

DOI

ISSN

1464-4096

Publication Date

September 2007

Volume

100

Issue

3

Start / End Page

639 / 645

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Urodynamics
  • Urinary Bladder, Neurogenic
  • Treatment Outcome
  • Spinal Cord Injuries
  • Retrospective Studies
  • Neuromuscular Agents
  • Neural Tube Defects
  • Male
  • Injections